Gilead Sciences (GILD) Inventory (2009 - 2026)
Gilead Sciences' (GILD) quarterly Inventory came in at $1.9 billion in Q1 2026, up 8.81% YoY from $1.8 billion in Q1 2025, and up 7.89% on a QoQ basis from $1.8 billion in Q4 2025.
Gilead Sciences (GILD) Inventory (2009 - 2026) Analysis & Trends
Gilead Sciences (GILD) has 18 years of Inventory data on file, last reported at $1.9 billion in Q1 2026.
- Quarterly Inventory rose 8.81% year-over-year to $1.9 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.9 billion (up 8.81% YoY) and the FY2025 annual result came in at $1.8 billion, up 3.74% from the prior year.
- Inventory improved to $1.9 billion in Q1 2026, from $1.8 billion in the prior quarter.
- In the past five years, Inventory ranged from a high of $2.0 billion in Q2 2024 to a low of $1.5 billion in Q3 2022.
- A 5-year average of $1.7 billion and a median of $1.8 billion in 2025 frame the typical range for Inventory.
- Annual changes were most pronounced in 2022 — Inventory retreated 16.69% — and 2024, when it climbed 24.07%.
- Tracing GILD's Inventory over 5 years: stood at $1.5 billion in 2022, then rose by 18.58% to $1.8 billion in 2023, then retreated by 4.31% to $1.7 billion in 2024, then rose by 3.74% to $1.8 billion in 2025, then gained by 7.89% to $1.9 billion in 2026.
- The last three Inventory figures came in at $1.9 billion (Q1 2026), $1.8 billion (Q4 2025), and $1.8 billion (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 15.14 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 5.13 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | 6.21 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 6.22 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 6.93 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 6.22 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | 1.95 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 9.95 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 8.43 Bn |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 12.93 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.95 Bn |
| Mar 31, 2026 | 1.91 Bn |
| Dec 31, 2025 | 1.77 Bn |
| Sep 30, 2025 | 1.79 Bn |
| Jun 30, 2025 | 1.83 Bn |
| Mar 31, 2025 | 1.76 Bn |
| Dec 31, 2024 | 1.71 Bn |
| Sep 30, 2024 | 1.87 Bn |
| Jun 30, 2024 | 2.03 Bn |
| Mar 31, 2024 | 1.85 Bn |
| Dec 31, 2023 | 1.79 Bn |
| Sep 30, 2023 | 1.66 Bn |
| Jun 30, 2023 | 1.63 Bn |
| Mar 31, 2023 | 1.58 Bn |
| Dec 31, 2022 | 1.51 Bn |
| Sep 30, 2022 | 1.46 Bn |
| Jun 30, 2022 | 1.49 Bn |
| Mar 31, 2022 | 1.48 Bn |
| Dec 31, 2021 | 1.62 Bn |
| Sep 30, 2021 | 1.68 Bn |